Hot Stocks Earnings Forecast: Bank of America, MGM Resorts International, Pfizer, Micron, Alpha Natural Resources, and Cheniere Energy
VANCOUVER, British Columbia, Dec. 7, 2012 /PRNewswire/ -- EarningForecast.com has issued consensus earnings forecast reports and equity research for the following companies: Bank of America (NYSE: BAC), MGM Resorts International (NYSE: MGM), Pfizer (NYSE: PFE), Micron (NASDAQ: MU), Alpha Natural Resources (NYSE: ANR), and Cheniere Energy (AMEX: LNG).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Bank of America Corporation (NYSE: BAC): Bank of America Corporation (NYSE: BAC) will post its financial results for fourth-quarter 2012 on Thursday, January 17, 2013. Shares of Bank of America ended lower by 0.05% to US$10.45 and made a new 52-week high of US$10.58 on over 176.17 million shares, compared to its average volume of 154.41 million shares. Investors may want to find out where BAC will go from here. Observe comprehensive Bank of America earnings forecast report here.
Read Full Report: http://www.earningforecast.com/PR/120712A/BAC/BankofAmerica.pdf
MGM Resorts International (NYSE: MGM): On December 6, MGM Resorts International (NYSE: MGM) announced a public offering of US$1.25 billion in aggregate principal amount of 6.625% senior unsecured notes due 2021 at par. The transaction is expected to close on December 20, 2012. What's more, the company recently announced the appointment of Bill Hornbuckle as President and Chief Marketing Officer. Observing comprehensive analysis of MGM Resorts International could help investors avoid big lost in investment. Add MGM earnings forecast report into your watch list now.
Pfizer Inc. (NYSE: PFE): In late November, Pfizer Inc. (NYSE: PFE) completed the sale of its Nutrition business to Nestlé for US$11.85 billion in cash. Pfizer also completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. Its price, as of the latest close, US$25.61, was up 27% compared with the 52-week low and was 2% below the 52-week high. Do you think now is a good time to buy or sell PFE? See Pfizer earnings forecast report here.
Read Full Report: http://www.earningforecast.com/PR/120712A/PFE/Pfizer.pdf
Today EarningForecast.com also observed abnormal trade volume for the following companies; Check out the consensus earnings forecast reports below:
Micron Technology, Inc. (NASDAQ: MU):
Read Full Report: http://www.earningforecast.com/PR/120712A/MU/Micron.pdf
Alpha Natural Resources, Inc. (NYSE: ANR):
Read Full Report: http://www.earningforecast.com/PR/120712A/ANR/AlphaNaturalResources.pdf
Cheniere Energy, Inc. (AMEX: LNG):
Read Full Report: http://www.earningforecast.com/PR/120712A/LNG/CheniereEnergy.pdf
EarningForecast.com focuses on tracking and monitoring company Earnings Data for top market movers in US stocks market. EarningForecast.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit: EarningForecast.com/disclaimers/index.php for details.